Detalhe da pesquisa
1.
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
N Engl J Med
; 384(19): 1824-1835, 2021 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33440088
2.
Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
PLoS Pathog
; 11(1): e1004565, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25569444
3.
Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
PLoS Pathog
; 9(2): e1003173, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23468623
4.
HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?
J Virol
; 87(7): 4043-51, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23365442
5.
Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.
J Virol
; 85(17): 8894-902, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21715491
6.
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors.
Hum Vaccin
; 7(6): 639-45, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21508675
7.
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
J Virol
; 82(7): 3555-60, 2008 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18234789
8.
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
PLoS One
; 10(5): e0125954, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25961283
9.
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.
J Immunol Methods
; 409: 161-73, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24291126
10.
Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.
Virology
; 449: 254-62, 2014 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-24418560
11.
Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
AIDS
; 27(17): 2775-86, 2013 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-24113395
12.
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.
Virology
; 436(1): 33-48, 2013 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-23123038
13.
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
PLoS One
; 7(8): e41936, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22870265
14.
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
Virology
; 366(1): 40-50, 2007 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17498767
15.
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.
J Gen Virol
; 87(Pt 9): 2571-2576, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16894195
16.
The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
J Virol
; 76(17): 8953-7, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12163614
17.
CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.
J Virol
; 76(6): 3059-64, 2002 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-11861874
18.
CD81 is an entry coreceptor for hepatitis C virus.
Proc Natl Acad Sci U S A
; 101(19): 7270-4, 2004 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-15123813
19.
Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.
J Virol
; 77(24): 13418-24, 2003 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-14645599
20.
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.
Proc Natl Acad Sci U S A
; 101(39): 14067-72, 2004 Sep 28.
Artigo
Inglês
| MEDLINE | ID: mdl-15371595